Most Recent
The Commonwealth Bank wants Cornwalls to pay its costs in a negligence case by a former client, saying the law firm should foot the bill for claiming proportionate liability against the bank.
The Law Council says asserting legal professional privilege is not "inherently scandalous", ahead of a parliamentary hearing on KPMG's sharing ofclient information, at which law firms Allens and Ashurst are expected to stay mum.
A former financial advisor and his company have won court approval to run a claim challenging AMP's buyer of last resort policy, despite the company being a group member in a related class action that settled for $100 million in 2023.
KPMG has been referred to the national corruption watchdog, with Greens Senator Barbara Pocock calling the federal government's three-month pause on new contracts with the auditor a “slap on the wrist with a stick of limp celery”.
Construction PRO
After a successful appeal of a decision found to be "personal and idiosyncratic", a Sydney developer can move ahead with plans to demolish a boarding house to make way for four luxury residences in Paddington.
Construction PRO
A court has found a Pelligra Group unit validly terminated leases for offices in a Melbourne CBD building rented by Birdies Mini Golf owner Stephanie Doyle after she failed to meet a deadline for agreement on floorplans.
Construction PRO
Japanese company Inpex has reached a workplace agreement with two unions, after the Fair Work Commission rejected the company’s urgent bid to halt industrial action at its Darwin Ichthys onshore and offshore LNG facilities.
Construction PRO
Hall & Wilcox has hired a property and disputes lawyer and his team of three to build out its offering in Adelaide.
Construction PRO
MinterEllison has elevated seven lawyers to its partnership, including four disputes specialists, as the firm anticipates litigation over major projects and AI-related class actions.
Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark.